Rett syndrome (RTT) is a genetic brain disorder which typically becomes apparent after 6 to 18 months of age in females. Symptoms include problems with language, coordination, and repetitive movements. Often there is slower growth, problems walking, and a smaller head size.
This report contains market size and forecasts of Rett Syndrome in Global, including the following market information:
Global Rett Syndrome Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Rett Syndrome market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
BHV-5000 Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Rett Syndrome include Anavex Life Sciences Corp., Neuren Pharmaceuticals Limited, Neuroloxis, Newron Pharmaceuticals, GW Pharmaceuticals Plc, Eloxx Pharmaceuticals Ltd, AveXis Inc, Amorsa Therapeutics Inc and AMO Pharma Ltd. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Rett Syndrome companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Rett Syndrome Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Rett Syndrome Market Segment Percentages, by Type, 2021 (%)
BHV-5000
Bryostatin-1
CPT-157633
ELX-02
Others
Global Rett Syndrome Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Rett Syndrome Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Others
Global Rett Syndrome Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Rett Syndrome Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Rett Syndrome revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Rett Syndrome revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Anavex Life Sciences Corp.
Neuren Pharmaceuticals Limited
Neuroloxis
Newron Pharmaceuticals
GW Pharmaceuticals Plc
Eloxx Pharmaceuticals Ltd
AveXis Inc
Amorsa Therapeutics Inc
AMO Pharma Ltd